Dementia and drug discovery: interview with Prof Paul Whiting

In honor of Dementia Awareness Week (16–22 May), we spoke to Professor Paul Whiting, Chief Scientific Officer for Alzheimer's Research UK's University College London Drug Discovery Institute, covering the work being done by his research network, the complexities of studying the brain and his hopes for the future of the field.

Jun 01, 2016
0
0

MedChemNet would like to thank Alzheimer's Research UK for their kind assistance in organizing this interview, and would like to encourage our viewers to visit their website to learn more about, and support, their honorable mission: www.alzheimersresearchuk.org

Stella Bennett

Contributor, Future Science Group

No comments yet.